Randomized 3-arm, phase 2 study of temsirolimus (CCI-779) in combination with letrozole in postmenopausal women with locally advanced or metastatic breast cancer-Reference-Cited by-同舟云学术

Randomized 3-arm, phase 2 study of temsirolimus (CCI-779) in combination with letrozole in postmenopausal women with locally advanced or metastatic breast cancer

Published:2005-06 Issue:16_suppl Volume:23 Page:564-564
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Carpenter J. T.¹,Roché H.¹,Campone M.¹,Colomer R.¹,Jagiello-Gruszfeld A.¹,Moore L.¹,D’Amore M.¹,Kong S.¹,Boni J.¹,Baselga J.¹

Affiliation:

1. Univ of Alabama at Birmingham, Birmingham, AL; Inst Claudius Regaud, Toulouse, France; Ctr René Gauducheau, Saint Herblain, France; Inst Catala d’Oncologia, Girona, Spain; Regional Cancer Ctr of Olsztyn, Olsztyn, Poland; Wyeth Research, Cambridge, MA; Wyeth Research, Collegeville, PA; Hosp Vall d’Hebron, Barcelona, Spain

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/jco.2005.23.16_suppl.564

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimising endocrine therapy in postmenopausal women with advanced breast cancer;Endocrine-Related Cancer;2018-07

2. Risk of adverse events with the addition of targeted agents to endocrine therapy in patients with hormone receptor-positive metastatic breast cancer: A systematic review and meta-analysis;Cancer Treatment Reviews;2018-01

3. Advances in the treatment of advanced oestrogen-receptor-positive breast cancer;The Lancet;2017-06

4. The Role of mTOR Inhibitors in Breast Cancer;mTOR Inhibition for Cancer Therapy: Past, Present and Future;2016

5. Managing Postmenopausal Women with Hormone Receptor-Positive Advanced Breast Cancer Who Progress on Endocrine Therapies with Inhibitors of the PI3K Pathway;The Breast Journal;2014-05-26